1. Kawana R, Kitamura T, Nakagomi O et al. Inactivation of human viruses by povidone-iodine in comparison with other antiseptics. Dermatology 1997; 195 (Suppl 2): 29-35.

2. Shiraishi T, Nakagawa Y. Evaluation of the bactericidal activity of povidone-iodine and commercially available gargle preparations. Dermatology 2002; 204 (Suppl 1): 37-41.

3. Jayaraja Kumar K et al. Application of broad spectrum antiseptic povidone iodine as powerful action: a review. J Pharmaceutical Science Technology 2009; 1 (2): 48-58.

4. Povidone-Iodine (BETADINE®) 1% Gargle & Mouthwash Product Label.

5. Whittaker C. Sore throats and halitosis. SA Pharmacist’s Assistant 2010; 10 (1); 12-16.

6. Worrall G. Acute sore throat. Canadian Family Physician 2011; 57: 791-794.

7. Kanagalingam J. Practical use of povidone-iodine antiseptic in the maintenance of oral health and in the prevention and treatment of common oropharyngeal infections. The International Journal of Clinical Practice 2015. DOI: 10.1111/ijcp.12707.

8. Lachapelle J et al. Antiseptics in the era of bacterial resistance: a focus on povidone iodine. Clin. Pract. 2013; 10(5): 579-592.

9. Company Core Data Sheet (CCDS): Povidone-iodine (Mundipharma).

10. Ghogawala Z and Furtado O. In vitro and in vivo bactericidal activities of 10%, 2.5%, and 1% povidone-iodine solution. Am J Hosp Pharm 1990;47:1562-1566.